Long-term culture and characterization of human neurofibroma-derived Schwann cells

Journal of Neuroscience Research

Volumn 61, Issue 5, 2000, Pages 524-532

  Rosenbaum, Thorsten ^a   Rosenbaum, Claudia ^a   Winner, Ursula ^a   Müller, Hans Werner ^a   Lenard, Hans Gerd ^a   Hanemann, C Oliver ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Cell culture; Neurofibroma; Neurofibromatosis; NF1; Proliferation; Schwann cell

Indexed keywords

NEUROFIBROMIN;

ANGIOGENESIS; ARTICLE; CAPILLARY PROLIFERATION; CARCINOGENESIS; CELL CULTURE; CONTROLLED STUDY; GENE MUTATION; GENETIC HETEROGENEITY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; ISOLATED ORGAN; MAST CELL; MUTATION; NEURINOMA; NEUROFIBROMA; NEUROFIBROMATOSIS; PHENOTYPE; PRIORITY JOURNAL; SCHWANN CELL; SEQUENCE HOMOLOGY;

EID: 0034284169     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-4547(20000901)61:5<524::AID-JNR7>3.0.CO;2-Z     Document Type: Article

References (41)

1. Neurofibromatosis and cancer
2. Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients
3. Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in murine and human hematopoietic cells
4. Characterization of full-length neurofibromin: Tubulin inhibits Ras GAP activity
5. Differential expression of two mRNA species indicates a dual function of peripheral myelin protein PMP22 in cell growth and myelination
6. Growth of a neuroblastoma cell line in serum free supplemented medium
7. Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues
8. Studies on cultured rat Schwann cells. 1. Establishment of purified populations from cultures of peripheral nerve
9. Benign neurofibromas in type neurofibromatosis (NF1) show somatic deletions of the NF1 gene
10. The protein product of the neurofibromatosis type 1 gene is expressed at highest abundance in neurons, Schwann cells, and oligodendrocytes
11. Identification and characterization of the neurofibromatosis type 1 protein product
12. Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis
13. Molecular and cytogenetic analysis of tumors in von Recklinghausen neurofibromatosis
14. Neurofibromatosis type 1 gene product (neurofibromin) associates with microtubules
15. Identification neurofibromatosis type 1 gene product
16. Improved culture methods to expand Schwann cells with altered growth behavior from CMT1A patients
17. Tumor predisposition in mice heterozygous for a targeted mutation of NF1
18. Schwann cells from Neurofibromin-deficient mice exhibit activation of p21ras, inhibition of cell proliferation and morphologic changes
19. Nf1-deficient mouse Schwann cells are angiogenic and invasive and can be induced to hyperproliferate: Reversion of some phenotypes by an inhibitor of farnesyl protein transferase
20. Neurofibromatosis 1 GTPase activating protein-related domain and its functional significance
21. Stimulation of mitosis of cultured rat Schwann cells isolated by differential adhesion
22. The influence of heregulins on human Schwann cell proliferation
23. Ras signaling and NF1
24. Chromosome 17p deletions and p53 mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis
25. The effects of cAMP on differentiation of cultured Schwann cells: Progression from an early phenotype (04+) to a myelin phenotype (Po+, GFAP-, N-CAM-, NGF-receptor-) depends on growth inhibition
26. NIH conference: Neurofibromatosis 1 (Recklinghausen disease) and neurofibromatosis 2 (bilateral acoustic neurofibromatosis). An update
27. Cellular differentiation and expression of matrix genes in type 1 neurofibromatosis
28. Neurofibromatosis tumor and skin cells in culture. II. Structural proteins with special reference to the cytoskeletal and cell surface components
29. Schwann-like cells cultured from human dermal neurofibromas. Immunohistological identification and response to Schwann cell mitogens
30. Ras-mediated cell cycle arrest is altered by nuclear oncogens to induce Schwann cell transformation
31. Isolation and characterization of Schwann cells from neurofibromatosis type 2 patients
32. Neurofibromin deficient fibroblasts fail to form perineurium in vitro
33. Neurofibromin, the neurofibromatosis type 1 (NF1) Ras-GAP, is required for appropriate P0 expression and myelination
34. Neurofibromatosis type 1: Genetic and cellular mechanisms of peripheral nerve tumor formation
35. Purification and expansion of human Schwann cells in vitro
36. Identification of NF1 mutations in both alleles of a dermal neurofibroma
37. Confirmation of a double-hit model for the NF1 gene in benign neurofibromas
38. Angiogenic and invasive properties of neurofibroma Schwann cells
39. The neurofibromatosis type 1 gene
40. Type 1 neurofibromatosis gene: Identification of a large transcript disrupted in three NF1 patients